Table 3. Ten-year relative survival for the 1994–1998 period compared to 10-year relative survival of patients diagnosed in 1984–1998 (‘full cohort') and patients diagnosed in 1994–1998 (‘restricted cohort').
| |
10-year relative survivala |
Change from |
Difference from period 1994–1998 |
|||
|---|---|---|---|---|---|---|
| Cancer | Period 1994–1998 PE (SE) | Full cohort 1984–1998 PE (SE) | Restricted cohort 1994–1998 PE (SE) | 1984–1988 to 1994–1998 | Full cohort 1984–1998 | Restricted cohort 1994–1998 |
| Oral cavity |
56.1 (1.9) |
55.3 (1.1) |
53.4 (1.8) |
−2.7 |
−0.75 |
−2.73 |
| Multiple myeloma |
16.8 (1.3) |
15.6 (0.7) |
16.2 (1.2) |
−1.5 |
−1.25 |
−0.57 |
| Pancreas |
2.6 (0.4) |
2.2 (0.2) |
1.8 (0.3) |
−0.5 |
−0.45 |
−0.79 |
| Trachea, lung and bronchus |
7.2 (0.4) |
7.1 (0.2) |
7.2 (0.4) |
−0.4 |
−0.1 |
−0.05 |
| Oesophagus |
8.7 (1.2) |
7.4 (0.6) |
8.4 (1.1) |
1.4 |
−1.24 |
−0.31 |
| Gallbladder |
6.7 (1.4) |
7.3 (0.8) |
8.0 (1.3) |
1.4 |
0.61 |
1.31 |
| Liver |
3.2 (0.8) |
2.8 (0.4) |
3.0 (0.7) |
1.5 |
−0.43 |
−0.23 |
| Larynx |
49.8 (5.0) |
50.1 (2.4) |
55.3 (4.3) |
1.5 |
0.21 |
5.43 |
| Brain and nervous system |
9.8 (1.0) |
10.4 (0.6) |
12.1 (0.9) |
2.2 |
0.54 |
2.26 |
| Skin melanoma |
75.2 (2.4) |
72.9 (1.2) |
73.9 (1.9) |
3.1 |
−2.31 |
−1.27 |
| Leukaemias |
25.9 (1.4) |
23.1 (0.7) |
25.5 (1.2) |
4.3 |
−2.81 |
−0.42 |
| Cervix |
48.8 (2.9) |
45.0 (1.5) |
47.5 (2.7) |
4.8 |
−3.8 |
−1.33 |
| Bladder |
66.2 (1.6) |
61.9 (0.8) |
65.3 (1.3) |
5.9 |
−4.25 |
−0.87 |
| Stomach |
22.0 (0.9) |
20 (0.5) |
22.8 (0.9) |
6.6 |
−1.98 |
0.82 |
| Female breast |
68.7 (0.9) |
67.9 (0.5) |
71.8 (0.7) |
6.6 |
−0.76 |
3.13 |
| Corpus uteri |
74.3 (1.6) |
73.0 (0.9) |
77.2 (1.4) |
6.9 |
−1.35 |
2.9 |
| Non-Hodgkin lymphoma |
37.5 (1.3) |
36.0 (0.7) |
38.8 (1.0) |
7.1 |
−1.43 |
1.31 |
| Colorectal |
49.6 (0.9) |
47.6 (0.5) |
52.2 (0.8) |
7.7 |
−2.03 |
2.56 |
| Ovarian |
29.1 (1.2) |
27.2 (0.7) |
29.4 (1.2) |
7.8 |
−1.85 |
0.31 |
| Thyroid |
69.9 (2.9) |
67.4 (1.6) |
72.8 (2.6) |
10.7 |
−2.56 |
2.86 |
| Kidney |
45.1 (1.5) |
42.2 (0.8) |
47.1 (1.3) |
12.7 |
−2.89 |
2.05 |
| Hodgkin lymphoma |
47.5 (4.5) |
42.6 (2.4) |
48.4 (5.1) |
12.9 |
−4.82 |
0.97 |
| Prostate | 45.6 (1.2) | 52.1 (0.9) | 62.9 (1.3) | 17.4 | 6.48 | 17.34 |
PE=point estimate; SE=standard error.
Finnish Cancer Registry, 23 most common forms of cancer.
a
All survival estimates were age-adjusted to the International Standard Cancer Populations proposed by Corazziari et al (2004).